Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
RenovoRx, Inc. | Chief Clinical Officer | Options | 190K | Mar 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RNXT | RenovoRx, Inc. | Mar 6, 2024 | 1 | $0 | 4 | Mar 8, 2024 | Chief Clinical Officer |
RNXT | RenovoRx, Inc. | Mar 1, 2024 | 0 | $0 | 3 | Mar 8, 2024 | Chief Clinical Officer |